| Product Code: ETC9964708 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Dyskinesia Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Dyskinesia Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Dyskinesia Market - Industry Life Cycle |
3.4 United States (US) Dyskinesia Market - Porter's Five Forces |
3.5 United States (US) Dyskinesia Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 United States (US) Dyskinesia Market Revenues & Volume Share, By Drug class, 2021 & 2031F |
3.7 United States (US) Dyskinesia Market Revenues & Volume Share, By End-User, 2021 & 2031F |
3.8 United States (US) Dyskinesia Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 United States (US) Dyskinesia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Dyskinesia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders leading to dyskinesia |
4.2.2 Growing aging population in the US |
4.2.3 Advancements in medical technology and treatment options for dyskinesia |
4.3 Market Restraints |
4.3.1 High cost of dyskinesia treatment and management |
4.3.2 Stringent regulatory requirements for drug approval and market entry |
4.3.3 Limited awareness and understanding of dyskinesia among healthcare professionals and patients |
5 United States (US) Dyskinesia Market Trends |
6 United States (US) Dyskinesia Market, By Types |
6.1 United States (US) Dyskinesia Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Dyskinesia Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 United States (US) Dyskinesia Market Revenues & Volume, By Athetosis, 2021- 2031F |
6.1.4 United States (US) Dyskinesia Market Revenues & Volume, By Chorea, 2021- 2031F |
6.1.5 United States (US) Dyskinesia Market Revenues & Volume, By Levodopa-induced or Parkinsons Dyskinesia, 2021- 2031F |
6.1.6 United States (US) Dyskinesia Market Revenues & Volume, By Tardive or Delayed Dyskinesia, 2021- 2031F |
6.1.7 United States (US) Dyskinesia Market Revenues & Volume, By Myoclonus Dyskinesia, 2021- 2031F |
6.2 United States (US) Dyskinesia Market, By Drug class |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Dyskinesia Market Revenues & Volume, By Dopamine-depleting, 2021- 2031F |
6.2.3 United States (US) Dyskinesia Market Revenues & Volume, By GABA Receptor Agonists, 2021- 2031F |
6.2.4 United States (US) Dyskinesia Market Revenues & Volume, By Anti-cholinergics, 2021- 2031F |
6.2.5 United States (US) Dyskinesia Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Dyskinesia Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Dyskinesia Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United States (US) Dyskinesia Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.4 United States (US) Dyskinesia Market Revenues & Volume, By CROs, 2021- 2031F |
6.3.5 United States (US) Dyskinesia Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Dyskinesia Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Dyskinesia Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 United States (US) Dyskinesia Market Revenues & Volume, By Parenterals, 2021- 2031F |
6.4.4 United States (US) Dyskinesia Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Dyskinesia Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Dyskinesia Market Revenues & Volume, By Online Distribution, 2021- 2031F |
6.5.3 United States (US) Dyskinesia Market Revenues & Volume, By Offline Distribution, 2021- 2031F |
7 United States (US) Dyskinesia Market Import-Export Trade Statistics |
7.1 United States (US) Dyskinesia Market Export to Major Countries |
7.2 United States (US) Dyskinesia Market Imports from Major Countries |
8 United States (US) Dyskinesia Market Key Performance Indicators |
8.1 Patient adherence to dyskinesia treatment regimens |
8.2 Number of clinical trials for new dyskinesia treatments |
8.3 Adoption rate of innovative therapies for dyskinesia |
9 United States (US) Dyskinesia Market - Opportunity Assessment |
9.1 United States (US) Dyskinesia Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 United States (US) Dyskinesia Market Opportunity Assessment, By Drug class, 2021 & 2031F |
9.3 United States (US) Dyskinesia Market Opportunity Assessment, By End-User, 2021 & 2031F |
9.4 United States (US) Dyskinesia Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 United States (US) Dyskinesia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Dyskinesia Market - Competitive Landscape |
10.1 United States (US) Dyskinesia Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Dyskinesia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here